e-Edition
Obituaries
Photo Gallery
Magazines
News Crew
Paywall Login
Login to Comment
Register
December 15th, 2015
Menu
Home
News
Sports
Business
Entertainment
Federal Election
Classifieds
Life
Commentary
Contact
Local News
Provincial News
National News
World News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S
(NY:
NVO
)
72.83
USD
+0.31 (+0.43%)
Official Closing Price
Updated: 6:59 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
...
54
55
Next >
Better Buy: Abbott Laboratories vs. Novo Nordisk
February 13, 2020
These healthcare stocks can give investors a good mix of dividends and growth.
Tags
NVO
ABT
Market News
From
Motley Fool
A Pharmaceutical Stock That Is Often Particularly Strong At This Time Of The Year!
February 13, 2020
I consider investing in particularly strong seasonal phases and thus significantly increasing the chance of generating extraordinary returns a very appealing idea.
Tags
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Is Amgen a Stock to Buy?
February 08, 2020
Amgen’s pipeline and an oncology collaboration in China are reasons to believe the recent revenue slowdown may be transient.
Tags
AMGN
NVS
CHRS
From
Motley Fool
Coronavirus update: 565 deaths, more than 28,000 cases worldwide, Yum China reports ‘significant interruption
February 06, 2020
There are now 28,256 confirmed coronavirus cases in 25 countries and at least 565 deaths, according to the latest figures from the World Health Organization (WHO).
Tags
Entertainment and Leisure
YUMC
Travel
From
MarketWatch
The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs
February 06, 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ...
Tags
Earnings
MYGN
ALNY
From
Benzinga
13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market
February 05, 2020
Non-alcoholic steatohepatitis, or NASH, is a metabolic disorder caused by a buildup of fat in the liver, leading to liver inflammation ...
Tags
Market News
Top Stories
GLMD
From
Benzinga
Stocks That Hit 52-Week Highs On Wednesday
February 05, 2020
Before 10 a.m. ET on Wednesday, 298 companies set new 52-week highs. Areas of Significance: Microsoft(NASDAQ: ...
Tags
WLTW
SHOP
PHR
From
Benzinga
The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data
February 05, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Benzinga
PHAS
CCXI
From
Benzinga
Earnings Scheduled For February 5, 2020
February 05, 2020
Companies Reporting Before The Bell Merck & Co., Inc. (NYSE: MRK) is projected to report quarterly earnings at $1.15 per ...
Tags
SU
Benzinga
CINF
From
Benzinga
The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
January 17, 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ...
Tags
VIR
Market News
RCEL
From
Benzinga
The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
January 16, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Pre/Market Outlook
EPZM
RIGL
From
Benzinga
Stocks That Hit 52-Week Highs On Wednesday
January 15, 2020
On Wednesday, 277 companies set new 52-week highs. Noteworthy Points: NextEra Energy(NYSE: NEE)was the largest ...
Tags
LYV
FRTA
HESAY
From
Benzinga
The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
January 15, 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ...
Tags
GNMK
Guidance
HOLX
From
Benzinga
34 Healthcare Stocks Moving In Wednesday's Pre-Market Session
January 15, 2020
Gainers OrganiGram Holdings, Inc.(NASDAQ: OGI) shares increased by 26.9% to $2.74 during Wednesday's pre-market session. ...
Tags
Biotechnology
NVCN
OGI
From
Benzinga
The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
January 14, 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ...
Tags
INSP
NKTR
MTEM
From
Benzinga
Stocks That Hit 52-Week Highs On Friday
January 10, 2020
On Fridat, 330 companies reached new 52-week highs. Interesting Points: Microsoft(NASDAQ: MSFT)was the largest firm ...
Tags
MELR
UDHI
52 Week Highs
From
Benzinga
Facing criticism over insulin prices, drugmakers offer more affordable options
January 07, 2020
Eli Lilly and Novo Nordisk are separately offering help to people who are struggling to pay for their insulin, in a move that underscores how differently drugmakers are approaching the highly...
Tags
Health/Care
SNY
LLY
From
MarketWatch
Novo Nordisk's new insulin affordability offerings now available in the US
January 02, 2020
- My$99Insulin: All patients can purchase up to three vials or two packs of FlexPen®/FlexTouch®/Penfill® pens of any combination of insulins from Novo Nordisk Inc. for $99
From
PR Newswire
21 Healthcare Stocks Moving In Thursday's Pre-Market Session
January 02, 2020
Gainers Cassava Sciences, Inc.(NASDAQ: SAVA) stock rose 37.5% to $7.15 during Thursday's pre-market session. Innate ...
Tags
SVRA
HEXO
AMRN
From
Benzinga
Up More Than 20% This Year, Is Novo Nordisk Worth Buying?
December 31, 2019
Led by its diabetes lineup, Novo Nordisk could continue to deliver solid returns in 2020.
Tags
Market News
SNY
LLY
From
Motley Fool
Stocks That Hit 52-Week Highs On Friday
December 27, 2019
During Friday's morning trading, 326 companies set new 52-week highs. Key Facts: Apple(NASDAQ: AAPL)was the ...
Tags
PREIF
MPB
IWGFF
From
Benzinga
Best & Worst ADRs - Monday, Dec. 23
December 23, 2019
The top-ranked sectors in ADR universe this week are services, healthcare, industrial goods, and basic materials.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Here's Why Dicerna Pharmaceuticals Is Falling Today
December 20, 2019
What goes up must come down. But today's tumble means relatively little for investors with a long-term mindset.
Tags
DRNA
ARWR
NVO
From
Motley Fool
Good News Bad News Day
December 20, 2019
Sweden has been the first country to exit negative interest rates despite a long tradition of using them to cool off the economy. This may spread and hurt the US as year-end funding magnifies the...
Tags
Stocks / Equities
From
Blogs - TalkMarkets
The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data
December 18, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
VERU
NLTX
XLRN
From
Benzinga
The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO
December 17, 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ...
Tags
PRVL
DVAX
MRTX
From
Benzinga
Stock Upgrades: Novo Nordisk Shows Rising Relative Strength
December 16, 2019
Novo Nordisk shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83.
From
Investor's Business Daily
Better Buy: Eli Lilly vs. Merck
December 14, 2019
Which of these two pharmaceutical giants is poised to produce healthier returns?
Tags
ARQL
Market News
LLY
From
Motley Fool
Stock Upgrades: Novo Nordisk Shows Rising Relative Strength
December 11, 2019
Novo Nordisk sees its Relative Strength Rating reach the 80-plus level.
From
Investor's Business Daily
Best & Worst ADRs - Monday, Dec. 9
December 09, 2019
The top-ranked sectors in ADR universe this week are services, healthcare, and industrial goods.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
< Previous
1
2
3
4
5
6
7
8
9
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.